Treatment of patients with metastatic urothelial carcinoma and impaired renal function with single-agent docetaxel

Meletios A Dimopoulos; Charalambos Deliveliotis; Lia A. Moulopoulos; Christos Papadimitriou; Dionysios Mitropoulos; Αchilles Anagnostopoulos; P. Athanassiades; C Dimopoulos

doi:10.1016/s0090-4295(98)00150-2

Back

Treatment of patients with metastatic urothelial carcinoma and impaired renal function with single-agent docetaxel

Article 1998 en

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article1997

Docetaxel and cisplatin (DC) combination chemotherapy for metastatic urothelial cancer

Meletios A Dimopoulos, G. Louras, D Pantazopoulos, C. Deliveliotis, C. Constantinidis, C. Papadimitriou, Constantinos Papadimitris, Zacharias Kyriakakis, Dionysios Mitropoulos, V. Georgoulias

Article2011

Management of advanced bladder cancer in patients with impaired renal function

Evangelos Bournakis, Meletios A Dimopoulos, Aristotle Bamias

Article2005

The combination of gemcitabine and carboplatin as first‐line treatment in patients with advanced urothelial carcinoma

Aristotle Bamias, Lia A. Moulopoulos, Aggelos Koutras, Gerasimos Aravantinos, George Fountzilas, D. Pectasides, Efstathios Kastritis, D. Gika, Dimosthenis Skarlos, Helena Linardou, Haralabos P. Kalofonos, Meletios A Dimopoulos

Article2019

Optimal Rivaroxaban Dose in Asian Patients With Atrial Fibrillation and Normal or Mildly Impaired Renal Function

So-Ryoung Lee, Eue-Keun Choi, Kyungdo Han, Jin‐Hyung Jung, Seil Oh, Professor Gregory Lip

Article2019

P4769Optimal rivaroxaban dose in Asian patients with atrial fibrillation and normal or mildly impaired renal function

Eue-Keun Choi, S R Lee, Kyungdo Han, Jin‐Hyung Jung, Seil Oh, Professor Gregory Lip